Topics

In-vitro models reduce ‘risk and cost’ for topically-delivered generics

04:37 EST 5 Feb 2020 | Outsourcing-Pharma

Developers of generic drugs administered with topical drug delivery methods benefit from MedPharmâs in-vitro models to safely demonstrate bioequivalence.

Original Article: In-vitro models reduce ‘risk and cost’ for topically-delivered generics

NEXT ARTICLE

More From BioPortfolio on "In-vitro models reduce ‘risk and cost’ for topically-delivered generics"

Quick Search

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...